Merck Tagged Articles
FDA to review new type 2 diabetes treatment
The Food and Drug Administration (FDA) has started a review of Sanofi’s new once-daily type 2 diabetes drug lixisenatide. The drug was approved last month by European Union regulators, and will be marketed as Lyxumia. Sanofi has not yet selected
Fosamax maker ordered to pay $285,000 to woman who developed severe jawbone disease
Merck, makers of the osteoporosis drug Fosamax, was ordered to pay $285,000 to a woman who claimed the drug caused her to develop osteonecrosis of the jaw (ONJ) after dental surgery and that the company did not adequately warn about
Merck seeks approval for previously rejected combination cholesterol drug
Merck & Co. is resubmitting the drug application for its combination cholesterol-lower drug MK-0653C, which was rejected by the Food and Drug Administration (FDA) last March due to insufficient data.
Two autopsies reveal Gardasil antigens entered brain, potentially triggering inflammation and death
A postmortem analysis of two girls from different parts of the world who died after receiving injections of Merck’s human papillomavirus (HPV) vaccine Gardasil has uncovered some astonishing evidence that components of the vaccine may be capable of triggering auto-immune
Complaints accuse Merck of mumps vaccine fraud
An Alabama health care provider filed a lawsuit against Merck Monday, June 25, a week after a 2010 whistleblower lawsuit against the drug manufacturer was unsealed, revealing allegations that for a decade, Merck may have knowingly made and marketed a
Study shows shingles vaccine is safe, well tolerated
The shingles vaccine is generally safe and well tolerated for adults ages 50 and older, according to a study published in the Journal of Internal Medicine. Each year, more than a million adults in the United States develops shingles. It
Preteen girls more likely to experience adverse reactions after Gardasil shots
Preteen girls are more likely than older teens and women to experience adverse side effects within two weeks of receiving Merck’s Gardasil® vaccine, a new Kaiser Permanente study has found.
New study finds black women more prone to HPV infection, cervical cancer
A new study conducted at the University of South Carolina indicates human papillomavirus (HPV) infections tend to last longer in college-age black females than in their white peers, potentially exposing them to a higher risk of developing cervical cancer.